Unjha Formulations Balance Sheet Annual

BSE: 531762 | NSE: - | ISIN: INE576D01015 | Sector: Biotechnology & Drugs

23.06 -0.41 (-1.75%)Updated : 09 Jul 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023
Period End Date	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	4.56	4.93	3.41
Total Inventory	1.03	1.26	1.14
Cash Equivalents	0.64	0.87	0.01
Common Stock Total	4.48	4.48	4.48
Accounts Payable	1.17	2.04	0.94
Other Equity Total	-1.34	-1.75	-2.03
Other Currentliabilities Total	0.25	0.15	0.02
Other Current Assets Total	0.06	0.00	0.12
Total Assets	4.56	4.93	3.41
Total Equity	3.14	2.73	2.45
Total Common Shares Outstanding	0.45	0.45	0.45
Intangibles Net	0.50	0.50	-
Tangible Book Valueper Share Common Eq	5.89	4.98	4.36
Total Liabilities	1.42	2.20	0.96
Cashand Short Term Investments	0.64	0.87	0.01
Total Current Assets	3.35	3.81	2.31
Total Receivables Net	1.62	1.68	1.05
period Length	0.00	0.00	0.00
Deferred Income Tax	0.00	0.01	0.00
Accounts Receivable- Trade Net	1.51	1.61	1.05
Property/ Plant/ Equipment Total- Net	0.70	0.62	0.60
Total Current Liabilities	1.41	2.20	0.96
Total Debt	-	0.00	0.00
Notes Payable/ Short Term Debt	-	0.00	0.00
Total Long Term Debt	-	0.00	0.00
Goodwill Net	-	-	0.50